Prescription Drug Overdose: Boost for State Prevention

Quick Facts

Due DateJune 4, 2014 (Wednesday)
Award AmountUn-Known
Category of Funding ActivityHealth
Eligible Applicants
  • Others - State Departments of Health or their Bona Fide Agents

Program Description

The purpose of this funding is to advance and evaluate comprehensive state-level interventions for preventing prescription drug misuse, abuse, and overdose. Interventions of interest address patient and prescriber behaviors that drive the prescription drug overdose epidemic, particularly the misuse and inappropriate prescribing of opioid pain relievers. Specifically, awardees will perform activities that support at least two of the following complementary key prevention strategies to prevent prescription drug misuse, diversion, and overdose: enhancing and maximizing prescription drug monitoring programs (PDMPs); improving and evaluating state health insurance mechanisms to prevent prescription drug misuse, diversion, and overdose (e.g., via Medicaid or workers? compensation); and evaluating state-level laws, policies, and regulations (e.g., legislation regulating pain clinics, or supporting clinical practice guidelines). The primary outcomes of interest may vary by strategy. They might include programmatic outcomes (e.g., mandatory PDMP registration and use, enrollment in patient review and restriction programs), behavior change (e.g., decrease prescribing inconsistent with clinical guidelines, decreased doctor shopping), and/or health-related outcomes (e.g., decrease in emergency department visits due to misuse or abuse of controlled prescription drugs, decreased drug overdose death rate). State-level engagement is critical to the success of this FOA given the concentration of the authority to address the use and misuse of prescription drugs within state government. Multi-sector collaboration with partners that have shared authority over this issue is also needed (e.g., law enforcement, boards of pharmacy, medical boards, mental health and substance abuse services, medical centers, lead state agencies for Medicaid programs.) Applicants are therefore required to submit letters of support from state-level governmental entities and other partners depending on the strategies they pursue under their work plan.

General Information

Funding Opportunity NumberCDC-RFA-CE14-1404
Funding Opportunity TitlePrescription Drug Overdose: Boost for State Prevention
Opportunity CategoryHealth
Funding Instrument TypeCooperative Agreement
Category ExplanationNot Available
Number of Awards5
Cost Sharing or Matching RequirementNo
Posted DateApril 3, 2014 (Thursday)
Application Due DateJune 4, 2014 (Wednesday)
Application Archive DateJuly 4, 2014 (Friday)
Total Program Funding$ 6,000,000
Award AmountUn-Known
CFDA Number
  • 93.136 - Injury Prevention and Control Research and State and Community Based Programs

Eligible Applicants

  • Others - State Departments of Health or their Bona Fide Agents

Contact Information

Agency NameDepartment of Health and Human Services
Program Information WebsiteTHIS LINK IS NOT AN ACTIVE LINK. CLICK ON ?FULL ANNOUNCEMENT? AT THE TOP OF THIS PAGE TO ACTIVATE.
ContactOffice: Centers for Disease Control and Prevention
CDC
Procurement and Grants Office (PGO)
Technical Information Management Section (TIMS)
Phone: 770-488-2700
Technical Information Management Section (TIMS)

Search Federal Grants

Application Due Date:
-